Optinose share price today

(OPTN)

Optinose share price is $0.42 & ₹35.69 as on 21 Dec 2024, 2.30 'hrs' IST

$0.42

Market is closed - opens 8 PM, 23 Dec 2024

View live Optinose share price in Dollar and Rupees. Guide to invest in Optinose from India. Also see the sentimental analysis on Indian investors investing in Optinose. Get details on the Indian mutual funds that are investing in Optinose. Get Analyst recommendations and forecasts along with all the Optinose's financials.

Optinose share price movements

Today's Low: $0.42
Today's High: $0.46
$0.42
1.19%
Downside
Day's Volatility :9.76%
Upside
8.68%
52 Weeks Low: $0.32
52 Weeks High: $2.10
$0.42
23.57%
Downside
52 Weeks Volatility :84.71%
Upside
80.0%

Optinose Returns

Period	Optinose Inc	Index (Russel 2000)
3 Months	-41.39%	0.0%
6 Months	-60.56%	0.0%
1 Year	-64.24%	0.0%
3 Years	-74.11%	-17.3%

Optinose Key Statistics

in dollars & INR

Previous Close	$0.422
Open	$0.415
Today's High	$0.4599
Today's Low	$0.415
Market Capitalization	$63.7M
Today's Volume	$447.9K
52 Week High	$2.1
52 Week Low	$0.321
Revenue TTM	$75.7M
EBITDA	$-18.9M
Earnings Per Share (EPS)	$-0.29
Profit Margin	-41.16%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1050.5%

How to invest in Optinose from India?

It is very easy for Indian residents to invest directly in Optinose from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Optinose stock in both Indian Rupees (INR) and US Dollars (USD). Search for Optinose or OPTN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Optinose or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Optinose shares which would translate to 2.023 fractional shares of Optinose as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Optinose, in just a few clicks!

Returns in Optinose for Indian investors in Rupees

Investment Value

₹1,00,000

Optinose investment value today

Current value as on today

₹1,66,502

Returns

₹66,502

(+66.5%)

Returns from Optinose Stock

₹64,407 (false-64.41%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Optinose

227%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Optinose on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 227% more investors are searching Optinose in the last 30 days versus the previous period.

Global Institutional Holdings in Optinose

FMR Inc
10.97%
MVM Partners LLC
9.68%
Nantahala Capital Management, LLC
9.52%
Great Point Partners LLC
9.10%
Rosalind Advisors, Inc.
5.49%
Stonepine Capital Management Llc
3.77%

Analyst Recommendation on Optinose

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Optinose(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Optinose

What analysts predicted

Upside of 614.29%

Current:

$0.42

Target:

$3.00

Insights on Optinose

Price Movement
In the last 1 month, OPTN stock has moved up by 15.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 20.49M → 20.43M (in $), with an average decrease of 0.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -14.06M → 467.0K (in $), with an average increase of 904.5% per quarter
OPTN vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 19.9% return, outperforming this stock by 82.9%
Price to Sales
ForOPTN every $1 of sales, investors are willing to pay $0.8, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Optinose Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.1M	↑ 4261.11%
Net Income	$-106.7M	↑ 118.11%
Net Profit Margin	-1.5K%	↑ 28676.75%

	FY19	Y/Y Change
Revenue	$34.6M	↑ 390.18%
Net Income	$-108.9M	↑ 2.14%
Net Profit Margin	-314.59%	↑ 1195.08%

	FY20	Y/Y Change
Revenue	$49.1M	↑ 41.83%
Net Income	$-98.3M	↓ 9.74%
Net Profit Margin	-200.2%	↑ 114.39%

	FY21	Y/Y Change
Revenue	$74.7M	↑ 51.99%
Net Income	$-81.7M	↓ 16.96%
Net Profit Margin	-109.37%	↑ 90.83%

	FY22	Y/Y Change
Revenue	$76.3M	↑ 2.18%
Net Income	$-76.4M	↓ 6.44%
Net Profit Margin	-100.16%	↑ 9.21%

	FY23	Y/Y Change
Revenue	$71.0M	↓ 6.93%
Net Income	$-35.5M	↓ 53.55%
Net Profit Margin	-49.99%	↑ 50.17%

	Q2 FY23	Q/Q Change
Revenue	$19.5M	↑ 64.22%
Net Income	$2.6M	↓ 114.08%
Net Profit Margin	13.5%	↑ 170.97%

	Q3 FY23	Q/Q Change
Revenue	$19.8M	↑ 1.9%
Net Income	$-9.3M	↓ 453.92%
Net Profit Margin	-46.88%	↓ 60.38%

	Q4 FY23	Q/Q Change
Revenue	$19.9M	↑ 0.21%
Net Income	$-10.0M	↑ 7.24%
Net Profit Margin	-50.17%	↓ 3.29%

	Q1 FY24	Q/Q Change
Revenue	$14.9M	↓ 25.09%
Net Income	$-14.1M	↑ 41.14%
Net Profit Margin	-94.54%	↓ 44.37%

	Q2 FY24	Q/Q Change
Revenue	$20.5M	↑ 37.7%
Net Income	$-7.6M	↓ 46.11%
Net Profit Margin	-37.0%	↑ 57.54%

	Q3 FY24	Q/Q Change
Revenue	$20.4M	↓ 0.26%
Net Income	$467.0K	↓ 106.16%
Net Profit Margin	2.29%	↑ 39.29%

	FY18	Y/Y Change
Profit	$5.5M	↑ 3280.86%

	FY19	Y/Y Change
Profit	$29.3M	↑ 435.64%

	FY20	Y/Y Change
Profit	$41.6M	↑ 41.79%

	FY21	Y/Y Change
Profit	$65.5M	↑ 57.47%

	FY22	Y/Y Change
Profit	$67.0M	↑ 2.31%

	FY23	Y/Y Change
Profit	$62.4M	↓ 6.95%

	Q2 FY23	Q/Q Change
Profit	$16.9M	↑ 66.5%

	Q3 FY23	Q/Q Change
Profit	$17.6M	↑ 4.24%

	Q4 FY23	Q/Q Change
Profit	$17.6M	↑ 0.09%

	Q1 FY24	Q/Q Change
Profit	$13.6M	↓ 22.98%

	Q2 FY24	Q/Q Change
Profit	$18.5M	↑ 36.44%

	Q3 FY24	Q/Q Change
Profit	$18.4M	↓ 0.74%

	FY18	Y/Y Change
Operating Cash Flow	$-91.8M	↑ 157.54%
Investing Cash Flow	$-1.7M	↓ 29.76%
Financing Cash Flow	$59.6M	↓ 74.77%

	FY19	Y/Y Change
Operating Cash Flow	$-90.8M	↓ 1.09%
Investing Cash Flow	$-557.0K	↓ 67.04%
Financing Cash Flow	$37.5M	↓ 37.01%

	FY20	Y/Y Change
Operating Cash Flow	$-86.2M	↓ 5.08%
Investing Cash Flow	$-546.0K	↓ 1.97%
Financing Cash Flow	$83.8M	↑ 123.32%

	FY21	Y/Y Change
Operating Cash Flow	$-76.9M	↓ 10.75%
Investing Cash Flow	$-62.0K	↓ 88.64%
Financing Cash Flow	$43.3M	↓ 48.31%

	FY22	Y/Y Change
Operating Cash Flow	$-67.7M	↓ 12.07%
Investing Cash Flow	$-63.0K	↑ 1.61%
Financing Cash Flow	$51.4M	↑ 18.73%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.5M	↑ 19.66%
Investing Cash Flow	$-79.0K	↑ 0.0%
Financing Cash Flow	$-1000.0	↓ 100.62%

Optinose Technicals Summary

Sell

Neutral

Buy

Optinose is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Optinose Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Optinose Inc	14.99%	-60.56%	-64.24%	-74.11%	-95.71%
Neurocrine Biosciences Inc.	9.47%	1.0%	5.07%	58.94%	24.49%
Haleon Plc Spon Ads	2.32%	12.27%	19.02%	30.9%	30.9%
Zoetis Inc.	-6.92%	-4.84%	-16.13%	-32.31%	23.53%
Viatris Inc.	-7.62%	15.85%	13.9%	-8.45%	-25.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Optinose Inc	NA	NA	NA	-0.2	-10.5	-0.1	NA	-0.24
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.56	28.56	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	31.33	31.33	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Optinose Inc	Buy	$63.7M	-95.71%	NA	-41.16%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.49%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.2B	30.9%	28.56	10.75%
Zoetis Inc.	Buy	$75.3B	23.53%	31.33	26.55%
Viatris Inc.	Hold	$14.6B	-25.76%	224.4	-5.87%

About Optinose

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo

Organization	Optinose
Employees	132
CEO	Dr. Ramy A. Mahmoud M.D., M.P.H.
Industry	Health Services

Management People of Optinose

Name	Title
Dr. Ramy A. Mahmoud M.D., M.P.H.	CEO & Director
Mr. Michael F. Marino Esq.	Chief Legal Officer & Corporate Secretary
Mr. P. Terence Kohler	Chief Financial Officer
Mr. Anthony J. Krick	VP of Finance & Chief Accounting Officer
Mr. Jonathan Neely	Vice President of Investor Relations & Business Development
Ms. Karen E. Brophy	Chief Human Resources Officer & VP of Human Resources

Important FAQs about investing in Optinose from India :

What is Optinose share price today?

Optinose share price today stands at $0.42, Open: $0.42 ; Previous Close: $0.42 ; High: $0.46 ; Low: $0.42 ; 52 Week High: $2.10 ; 52 Week Low: $0.32. The stock opens at $0.42, after a previous close of $0.42. The stock reached a daily high of $0.46 and a low of $0.42, with a 52-week high of $2.10 and a 52-week low of $0.32.

Can Indians buy Optinose shares?

Yes, Indians can invest in the Optinose (OPTN) from India.

With INDmoney, you can buy Optinose at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Optinose at zero transaction cost.

How can I buy Optinose shares from India?

It is very easy to buy Optinose from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Optinose be purchased?

Yes, you can buy fractional shares of Optinose with INDmoney app.

What are the documents required to start investing in Optinose stocks?

To start investing in Optinose, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.